AI assistant
SciSparc Ltd. — Regulatory Filings 2021
Feb 10, 2021
35501_ffr_2021-02-10_30cfb661-fbac-4ed2-b548-b8a67f0c596f.zip
Regulatory Filings
Open in viewerOpens in your device viewer
6-K 1 ea135124-6k_scisparcltd.htm REPORT OF FOREIGN PRIVATE ISSUER
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of February 2021 (Report No. 2)
Commission file number: 001- 38041
SCISPARC LTD.
(Translation of registrant’s name into English)
16 Abba Hillel Road
Ramat Gan 5250608, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
CONTENTS
On February 10, 2021, SciSparc Ltd. (the “ Company ”) issued a press release titled: “SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate.” A copy of this press release is furnished herewith as exhibit 99.1.
Field: Page; Sequence: 2; Options: NewSection; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence
Field: /Page
EXHIBIT INDEX
| Exhibit No. | |
|---|---|
| 99.1 | Press release titled: “SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate.” |
Field: Page; Sequence: 3; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ Oz Adler | |
|---|---|
| Name: | Oz Adler |
| Title: | Chief Financial Officer |
3
Field: Rule-Page
Field: /Rule-Page